Every year about 1.5 million ticks bite someone in the Netherlands, especially between March and October. Most people will not get sick of that.

From 16 December 2019, pregnant women in the Netherlands will be offered the 22-week vaccination. With this vaccination, a pregnant woman protects her child and herself against whooping cough.

Active Lyme disease of the central nervous system cannot be detected with an ELISpot test.

The societal costs of Lyme disease have been determined for the Netherlands for the first time. The disease appears to cost nearly EUR 20 million each year.

Health effects due to exposure to titanium dioxide nanoparticles via food, food supplements and toothpaste cannot be excluded.

Addition of an extra adjuvant (additive) to the current pertussis vaccines could enhance the effectivity of these vaccines.

Lyme disease can cause a variety of complaints in patients. Laboratory tests for the disease can support medical practitioners in making a diagnosis but are not necessarily conclusive.

Both regulators and manufacturers need to evaluate and manage consumer health risks that may be posed by the use of nanomaterials in cosmetics.

The application of nanotechnology to design and produce medical devices is increasing. RIVM provides an overview of nanotechnology enabled medical devices.

The Netherlands is the first country where the burden of disease due to Lyme disease has been determined.